Cartiva has raised $6 million to back its musculoskeletal foot surgical products from a single investor just ahead of its first PMA review. The financing could be expanded to up to $8.5 million, according to an SEC filing. The startup has previously identified New Enterprise Associates, which has a partner on its board, as its primary investor.
Merck KGaA Chairman Karl-Ludwig Kley is feeling pretty good about the hard work his company has accomplished in the last three years or so. A tough series of job cuts helped it exceed cost-cutting goals.
Swiss drugmakers Roche and Novartis Oncology have told Australia to go fly a kite if it expects a company to market a cancer drug in the country without Pharmaceutical Benefits Scheme coverage. The two companies announced their boycott intentions ahead of a Monday hearing by a panel of Australia's Senate.
The venture capital invested in med tech startups dipped below $500 million during the first quarter--for the first time since the fourth quarter of 2013, according to the MoneyTree Report from PricewaterhouseCoopers and the National Venture Capital Association based on data provided by Thomson Reuters.
Terry Wohlers, president of 3-D printing consultancy Wohlers Associates, said 3-D printed body parts earned $537 million last year, an increase of 30%.
Swedish startup BoneSupport has raised $14 million to back the drug-eluting aspects of its synthetic bone substitute. Its injectable, antibiotic-eluting product Cerament G was CE marked in 2013 and is the first such product indicated to promote and protect healing in patients with bone infections.
Moody's Investors Service has given a thumbs-up to the credit outlook for big Chinese pharmaceutical companies, noting that a reform push by the government for more market-friendly policies and stronger safety guidelines promises sweeping changes to an industry sometimes viewed with suspicion because of safety lapses.
New Enterprise Associates has closed a pair of funds totaling $3.15 billion to invest in information technology and healthcare companies. And while med tech may not loom particularly large for NEA, the firm does have roughly a couple of dozen active medical device portfolio companies.
Sterilucent has raised almost $4 million just about 6 months after the FDA cleared its Sterilucent PSD-85 Hydrogen Peroxide Sterilizer for use in healthcare facilities with tough surroundings such as combat hospitals and disaster response sites.
EarlySense has brought a third strategic investor into its latest financing round, and Mitsui & Co. has partnered exclusively with the startup to market its continuous, contact-free patient monitoring solution to Japanese homes and hospitals.